Dexmedetomidine and Cognitive Dysfunction after Critical Illness: What Can (and Cannot) Be Extrapolated from Rodent Models

Anesthesiology. 2020 Aug;133(2):258-261. doi: 10.1097/ALN.0000000000003391.

Authors

Cameron W Paterson¹, Craig M Coopersmith

Affiliation

¹ From the Department of Surgery and Emory Critical Care Center, Emory University School of Medicine (C.W.P., C.M.C.) Lieutenant Medical Corps, United States Navy, Naval Reserve Officer Training Corps (C.W.P.), Atlanta, Georgia.

PMID: 32665488
DOI: 10.1097/ALN.0000000000003391

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Analgesics, Non-Narcotic
Animals
Cognitive Dysfunction / chemically induced
Cognitive Dysfunction / diagnosis
Cognitive Dysfunction / etiology*
Critical Care / trends
Critical Illness / therapy*
Dexmedetomidine / adverse effects
Dexmedetomidine / therapeutic use*
Disease Models, Animal*
Humans
Mice
Rodentia

Substances

Analgesics, Non-Narcotic
Dexmedetomidine